CMS recently issued a statement saying that it's continuing the Medicare Drug Price Negotiation Program but is leaving the door open for potential changes. Experts weighed in on what changes could be ...

Robert Califf addressed a range of issues, including AI, lack of nutrition resources at the FDA and how he evaluates the progress of precision medicine at the Precision Medicine World Conference in ...

Having timely, accurate data is essential for healthcare practices to boost operational efficiency. Scheduling appointments or managing provider and staff workloads are informed by the metrics a ...

Member engagement is a critical function of any health plan’s outcomes improvement strategy. How members interact with their health plans directly impacts satisfaction, health outcomes, and ...

Many predicted increased M&A activity in the digital health space in 2025, and so far they seem to be right. On Wednesday, telemedicine company Teladoc Health announced that it plans to acquire ...

Network data transfer speed on a dark background. The push for healthcare initiatives including value-based care and AI requires robust data sharing and timely access to healthcare data.

Fay, a digital nutrition therapy startup, has secured $50 million in Series B funding led by Goldman Sachs, the company announced on Wednesday. San Francisco-based Fay connects people to a network ...

The $5 trillion cost of healthcare has pushed Americans to the brink. Despite calls for consumers to take a more active role in reducing healthcare costs, the ugly truth is that the information ...

Little Otter, a digital family mental health company, has secured $9.5 million in strategic funding to expand its reach with Medicaid and commercial insurance plans, the company announced on ...

Bain Capital, an investment firm that has spread its life sciences bets mainly across companies developing novel new medicines, is acquiring Mitsubishi Tanabe Pharma Corporation in a multi-billion ...

From record-high drug shortages to the explosive popularity of GLP-1 medications and the intensifying battle over the 340B drug discount program, many of the biggest healthcare stories of 2024 ...